Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Stocks
BioMarin Pharmaceuticals
Business Segments
Products & Services
Products & Services
5 metrics
Total revenues
11 segments
Derivatives Designated as Cash Flow Hedging Instruments
1 segments
Revenue
6 segments
Payment received as percentage of net product sales
1 segments
R&D
3 segments